Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder

Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder

For a long time, Substance Use Disorders (SUDs) were not considered a component in the etiology of dementia. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders introduced substance-induced neurocognitive disorders, incorporating this notion to clinical practice. However,...

Full description

Bibliographic Details
Main Authors: Nerea Requena-Ocaña, Pedro Araos, Pedro J. Serrano-Castro, María Flores-López, Nuria García-Marchena, Begoña Oliver-Martos, Juan Jesús Ruiz, Ana Gavito, Francisco Javier Pavón, Antonia Serrano, Fermín Mayoral, Juan Suarez, Fernando Rodríguez de Fonseca
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
alcohol use disorder
addiction
neurodegeneration
cognitive impairment
dementia
neurofilament light chain protein
Online Access:https://www.mdpi.com/1422-0067/24/2/1183

Internet

https://www.mdpi.com/1422-0067/24/2/1183

Similar Items